Atomera Incorporated (ATOM) shares were rising 7.07% to trade at $15.0 in pre-market at last check. Atomera (ATOM) stock remained unchanged to close Monday’s session at $14.01. The stock volume remained 0.24 million shares, which was lower than the average daily volume of 0.29 million shares within the past 50 days. ATOM shares have fallen […]
What Drove Atomera (ATOM) Stock Up 7% On Tuesday? Read More »
Karyopharm Therapeutics Inc. (KPTI) is a commercial-stage biotherapeutics company engaged in developing cancer therapies. The company’s pioneer Selective Inhibitor of Nuclear Export compound technology was developed to address an oncogenesis mechanism of nuclear export dysregulation. XPOVIO is commercialized by the Company in three cancer indications. The company’s candidate pipeline treats endometrial cancer, myelofibrosis, and myelodysplastic
Karyopharm Theraapeutics Inc. (KPTI) Stock Sinking in Premarket. Here’s the Reason. Read More »
LXP Industrial Trust (LXP) is rising on the charts today, up 7.48% to trade at $16.10 at last check in premarket trading. On Monday, LXP Industrial shares fell -0.60% to close the day at $14.98. The volume of LXP shares traded was 2.66 million, which is higher than the average volume over the last three
What Caused The LXP Industrial (LXP) Stock To Rise On Tuesday? Read More »
The crypto market appears to be getting back on track as the market’s global capitalization has increased by 3% during the day as crossed back $2 trillion. The bullish outlook of the market presents various opportunities and we are here to help you out with it! Highlights of the week Here are the top developments
Crypto market back on track: Earn free crypto Read More »
ICOs are always an interesting investment potential; however, they do require in-depth research and due diligence. Here are some of the top active ICOs that you can look into: Anchor Protocol is a decentralized savings protocol that offers financial products on the blockchain of Terra. The platform ensures diversification to offer low volatility and high
Hot ICOs to Watch Out For Read More »
Tonix Pharmaceuticals Holding Corp. (TNXP) is a biotherapeutics company engaged in the discovery, licensing, acquisition, and development of therapeutics for different diseases. The company’s product pipeline consists of TNX-1800 as a COVID-19 vaccine. TNX-3500 and TNX-102 SL are under the clinical stage for treating COVID-19. TNX-102 SL is the company’s CNS candidate in Phase 3
Synthetic Biologics Inc. (SYN) shares have gained 9.67% at $0.312 in Tuesday’s premarket session. Synthetic Biologics (SYN) stock added 19.99% to finish the last trading session at $0.28. SYN stock recorded a trading volume of 6.86 million shares, which is below the average daily trading volume published for the last 50 days of 1.92 million
The bullish outlook of the cryptocurrency market has resulted in phenomenal gains for a lot of tokens during the past week. Here are some of the top gainers of the week: 2Shares (2SHARES) is the top gainer in our list as the cryptocurrency has surged upwards by a staggering 451% during the week while the
Top Weekly Gainers to watch out for: 2SHARES, CCAR, XDOGE, MELT, RDR Read More »
The bullish outlook of the market does not mean that there less losers. The volatility of the market ensures it is balanced all the time. Here are some of the top losers of the week: Galactic Kitty Fighters (GKF) is the top loser of the week with a loss of 98%; however, the token has
Top Weekly Losers: GKF, SLOT, LOOMI, COMFY, ESHARES Read More »
At last check in pre-market trading, shares of the diversified precision manufacturer of specialized components and solutions serving global industries, Broadwind Inc. (BWEN) were up 8.77% at $1.86. Broadwind (BWEN) stock closed the last session at $1.71, increasing 2.40% or $0.04. BWEN Shares fluctuated between $1.66 and $1.74 throughout the day. The number of shares
What Caused Broadwind (BWEN) Stock To Rise Nearly 9% Pre-Market? Read More »
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.